Nobiletin improves hepatic lipid deposition, oxidative stress, and inflammation in non-alcoholic fatty liver disease via the Nrf2/NF-κB signaling pathway (53). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.